Yonsei Med J.  2011 Mar;52(2):347-350. 10.3349/ymj.2011.52.2.347.

Serum Anti-Saccharomyces Cerevisiae Antibodies in Greek Patients with Behcet's Disease

  • 1First Department of Medicine, Athens University Medical School, Athens, Greece. kkonstan@med.uoa.gr
  • 2First Department of Medicine, Semmelweis University, Budapest, Hungary.
  • 32nd Department of Medicine, University of Debrecen, Debrecen, Hungary.
  • 4National Blood Transfusion Center of Greece, Aharnes, Greece.
  • 5Biostatistics Unit, Agricultural Univesrity of Athens, Athens, Greece.


We tested 59 Greek patients with Behcet's Disease (BD) for serum anti-Saccharomyces cerevisiae antibodies. No increase of these antibodies was detected in the cases compared to 55 healthy unrelated blood donors from the same population. This finding is in contrast with the correlation between Saccharomyces cerevisiae antibodies and BD as reported in other populations. It seems that environmental factors may contribute to disease expression in different populations, producing different effects according to the individual's genetic predisposition. Saccharomyces cerevisiae antibodies do not seem to be of any significance in the Greek population.


Anti-Saccharomyces cerevisiae antibodies; Behcet's disease; Greece

MeSH Terms

Antibodies, Fungal/*immunology
Behcet Syndrome/*immunology/microbiology
Case-Control Studies
Immunoglobulin A/immunology
Immunoglobulin G/immunology
Middle Aged
Saccharomyces cerevisiae/*immunology
Young Adult


  • Fig. 1 Distribution of IgA and IgG serum ASCA levels in 58 Greek BD patients and 55 healthy blood donors from the same population. ASCA, anti-Saccharomyces cerevisiae antiodies.


1. Zouboulis CC, Kötter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, et al. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J. 1997. 38:411–422.
2. Ben-Chetrit E, Yazici H. Thoughts on the proposed links between Behçet's disease and familial Mediterranean fever. Clin Exp Rheumatol. 2002. 20:S1–S2.
3. Hamuryudan V, Yurdakul S, Yazıcı H. Morbus Behçet. Rheumatology in Europe. 1997. 26:31–33.
4. Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T. Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. Hum Pathol. 1985. 16:790–795.
5. Wright VA, Chamberlain MA. Behçet's syndrome. Bull Rheum Dis. 1978-1979. 29:972–979.
6. Lewis KA, Graham EM, Stanford MR. Systematic review of ethnic variation in the phenotype of Behcet's disease. Scand J Rheumatol. 2007. 36:1–6.
7. Al-Araji A, Kidd DP. Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. Lancet Neurol. 2009. 8:192–204.
8. Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A. Behçet's disease in Familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum. 2000. 29:286–295.
9. O'Duffy JD. Behçet's disease. Curr Opin Rheumatol. 1994. 6:39–43.
10. Brautbar C, Chajek T, Ben-Tuvia S, Lamm L, Cohen T. A genetic study of Behçet''s disease in Israel. Tissue Antigens. 1978. 11:113–120.
11. Mahr A, de Menthon M, LaValley L, Guillevin L. HLA-B5(1) and risk of Bechet's Disease: A meta-analysis of genetic association studies. Clin Exp Rheumatol. 2008. 26(3):Suppl 50. S-5.
12. Altenburg A, Papoutsis N, Krause L, Zouboulis Ch. Association between HLA Class I phenotypes and clinical manifestations in Adamantiades-Behcet disease patients in Germany. Clin Exp Rheumatol. 2008. 26(3):Suppl 50. S-7.
13. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet. 1990. 335:1078–1080.
14. Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Behçet's Disease. Semin Arthritis Rheum. 1998. 27:197–217.
15. Krause I, Monselise Y, Milo G, Weinberger A. Anti-Saccharomyces cerevisiae antibodies--a novel serologic marker for Behçet's disease. Clin Exp Rheumatol. 2002. 20:4 Suppl 26. S21–S24.
16. Myriokefalitakis I, Balaouras K, Bastakis M, Karogianni S, Bozios P, Elezoglou A, et al. Chlamidia trachomatis as trigger point to Adamantiades-Behcet's disease flare: a series of four cases. Clin Exp Rheumatol. 2008. 26:3 Suppl 50. S-7.
17. Zervas J, Vayopoulos G, Sakellaropoulos N, Kaklamanis P, Fessas P. HLA antigens and Adamantiades-Behçet's disease (A-BD) in Greeks. Clin Exp Rheumatol. 1988. 6:277–280.
18. Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001. 96:730–734.
19. Vermeire S, Joossens S, Peeters M, Monsuur F, Marien G, Bossuyt X, et al. Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology. 2001. 120:827–833.
20. Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, et al. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol. 2001. 96:449–454.
21. Sendid B, Quinton JF, Charrier G, Goulet O, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol. 1998. 93:1306–1310.
22. Sutton CL, Yang H, Li Z, Rotter JI, Targan SR, Braun J. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut. 2000. 46:58–63.
23. Roussou E, Efthimiades A, Settas L. Bang D, Lee ES, Lee S, editors. Incidence of Adamantiades-Bechet's Disease in Greek prefecture inhabited by a mixed population of native Greeks and Greek refugees from Turkey. Bechet's Didease. 2000. Seoul, Korea: Design Mecca Publishing;65–67.
24. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998. 42:788–791.
25. Fresko I, Ugurlu S, Ozbakir F, Celik A, Yurdakul S, Hamuryudan V, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome. Clin Exp Rheumatol. 2005. 23:4 Suppl 38. S67–S70.
26. Choi CH, Kim TI, Kim BC, Shin SJ, Lee SK, Kim WH, et al. Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course. Dis Colon Rectum. 2006. 49:1849–1859.
27. Rhee SH, Kim YB, Lee ES. Comparison of Behcet's disease and recurrent aphthous ulcer according to characteristics of gastrointestinal symptoms. J Korean Med Sci. 2005. 20:971–976.
28. Yurdakul S, Günaydin I, Tüzün Y, Tankurt N, Pazarli H, Ozyazgan Y, et al. The prevalence of Behçet's syndrome in a rural area in northern Turkey. J Rheumatol. 1988. 15:820–822.
Full Text Links
  • YMJ
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr